相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Association of circulating CXCL10 and CXCL11 with systemic sclerosis
Clara Crescioli et al.
ANNALS OF THE RHEUMATIC DISEASES (2018)
Transforming Growth Factor β Activation Primes Canonical Wnt Signaling Through Down-Regulation of Axin-2
Justin Gillespie et al.
ARTHRITIS & RHEUMATOLOGY (2018)
CXCL10 increases in human skeletal muscle following damage but is not necessary for muscle regeneration
Michael R. Deyhle et al.
PHYSIOLOGICAL REPORTS (2018)
Muscle involvement in systemic sclerosis: points to consider in clinical trials
Ulrich A. Walker et al.
RHEUMATOLOGY (2017)
Measures of disease status in systemic sclerosis: A systematic review
Tien Tay et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2017)
Earliest Phase of Systemic Sclerosis Typified by Increased Levels of Inflammatory Proteins in the Serum
Marta Cossu et al.
ARTHRITIS & RHEUMATOLOGY (2017)
Inflammation and its resolution and the musculoskeletal system
Jiri Gallo et al.
JOURNAL OF ORTHOPAEDIC TRANSLATION (2017)
Angiostatic and angiogenic chemokines in systemic sclerosis: an overview
Silvia Bellando Randone et al.
JOURNAL OF SCLERODERMA AND RELATED DISORDERS (2017)
Phosphodiesterase type 5 inhibitors: back and forward from cardiac indications
C. Corinaldesi et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2016)
Phosphodiesterase Type 5 Inhibitor Sildenafil Decreases the Proinflammatory Chemokine CXCL10 in Human Cardiomyocytes and in Subjects with Diabetic Cardiomyopathy
Luigi Di Luigi et al.
INFLAMMATION (2016)
Biomarkers in systemic sclerosis: Their potential to predict clinical courses
Minoru Hasegawa
JOURNAL OF DERMATOLOGY (2016)
The CXCL10/CXCR3 Axis and Cardiac Inflammation: Implications for Immunotherapy to Treat Infectious and Noninfectious Diseases of the Heart
Raffaele Altara et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2016)
Stromal Cells in Chronic Inflammation and Tertiary Lymphoid Organ Formation
Christopher D. Buckley et al.
ANNUAL REVIEW OF IMMUNOLOGY VOL 33 (2015)
PDE5 inhibitors as therapeutics for heart disease, diabetes and cancer
Anindita Das et al.
PHARMACOLOGY & THERAPEUTICS (2015)
Phosphodiesterase 5 inhibition at disease onset prevents experimental autoimmune encephalomyelitis progression through immunoregulatory and neuroprotective actions
Paula Pifarre et al.
EXPERIMENTAL NEUROLOGY (2014)
Systemic Sclerosis and the Heart
John L. Parks et al.
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA (2014)
The Multifaceted Functions of CXCL10 in Cardiovascular Disease
Pleunie van den Borne et al.
BIOMED RESEARCH INTERNATIONAL (2014)
Vitamin D Receptor Agonists: Suitable Candidates as Novel Therapeutic Options in Autoimmune Inflammatory Myopathy
Clara Crescioli
BIOMED RESEARCH INTERNATIONAL (2014)
Correlation of interferon-inducible chemokine plasma levels with disease severity in systemic sclerosis
Xiaochun Liu et al.
ARTHRITIS AND RHEUMATISM (2013)
Vitamin D Receptor Agonists Target CXCL10: New Therapeutic Tools for Resolution of Inflammation
Sabino Scolletta et al.
MEDIATORS OF INFLAMMATION (2013)
CXCL10: A candidate biomarker in transplantation
Paola Romagnani et al.
CLINICA CHIMICA ACTA (2012)
Inflammatory response in human skeletal muscle cells: CXCL10 as a potential therapeutic target
Clara Crescioli et al.
EUROPEAN JOURNAL OF CELL BIOLOGY (2012)
Anti-Inflammatory and Cardioprotective Effects of Tadalafil in Diabetic Mice
Amit Varma et al.
PLOS ONE (2012)
EUSTAR biobanking: recommendations for the collection, storage and distribution of biospecimens in scleroderma research
Christian Beyer et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
Dysregulated expression of MIG/CXCL9, IP-10/CXCL10 and CXCL16 and their receptors in systemic sclerosis
Bradley J. Rabquer et al.
ARTHRITIS RESEARCH & THERAPY (2011)
Type I interferon system activation and association with disease manifestations in systemic sclerosis
Maija-Leena Eloranta et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Phosphodiesterase inhibitors in the management of autoimmune disease
Padmanabha Shenoy et al.
AUTOIMMUNITY REVIEWS (2010)
CXCR3, Inflammation, and Autoimmune Diseases
Stephanie Lacotte et al.
CONTEMPORARY CHALLENGES IN AUTOIMMUNITY (2009)
Enhanced expression of interferon-inducible protein-10 correlates with disease activity and clinical manifestations in systemic lupus erythematosus
K. O. Kong et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2009)
Immunomodulatory effects of BXL-01-0029, a less hypercalcemic vitamin D analogue, in human cardiomyocytes and T cells
M. Sottili et al.
EXPERIMENTAL CELL RESEARCH (2009)
Phosphodiesterase 5 Inhibition Improves Synaptic Function, Memory, and Amyloid-β Load in an Alzheimer's Disease Mouse Model
Daniela Puzzo et al.
JOURNAL OF NEUROSCIENCE (2009)
Phosphodiesterase 5A Inhibitors Improve Functional Recovery after Stroke in Rats: Optimized Dosing Regimen with Implications for Mechanism
Frank S. Menniti et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
Mechanisms of Disease: Scleroderma.
Armando Gabrielli et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Predictive Role of Pretransplant Serum CXCL10 for Cardiac Acute Rejection
Clara Crescioli et al.
TRANSPLANTATION (2009)
Decreased expression of caveolin 1 in patients with systemic sclerosis -: Crucial role in the pathogenesis of tissue fibrosis
Francesco Del Gaido et al.
ARTHRITIS AND RHEUMATISM (2008)
Immunosuppression in cardiac graft rejection: A human in vitro model to study the potential use of new immunomodulatory drugs
Clara Crescioli et al.
EXPERIMENTAL CELL RESEARCH (2008)
Human myoblasts modulate the function of antigen-presenting cells
Nicholas Schwab et al.
JOURNAL OF NEUROIMMUNOLOGY (2008)
Chemokine receptor CXCR3 and its ligands CXCL9 and CXCL10 are required for the development of murine cerebral malaria
Gabriele S. V. Campanella et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Sildenafil citrate therapy for pulmonary arterial hypertension
N Galiè et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
CXCR3/CXCL10 expression in the synovium of children with juvenile idiopathic arthritis
G Martini et al.
ARTHRITIS RESEARCH & THERAPY (2005)
Serum levels of a Th1 chemoattractant IP-10 and Th2 chemoattractants, TARC and MDC, are elevated in patients with systemic sclerosis
H Fujii et al.
JOURNAL OF DERMATOLOGICAL SCIENCE (2004)
Allergic humans are hypo-responsive to CXCR3 chemokines in a Th1 immunity-promoting loop
JD Campbell et al.
FASEB JOURNAL (2003)
Cushing's syndrome in a patient with bilateral macronodular adrenal hyperplasia responding to cisapride:: An in vivo and in vitro study
M Mannelli et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
European multicentre study to define disease activity criteria for systemic sclerosis.: II.: Identification of disease activity variables and development of preliminary activity indexes
G Valentini et al.
ANNALS OF THE RHEUMATIC DISEASES (2001)
Cutting edge: The T cell chemoattractant IFN-inducible protein 10 is essential in host defense against viral-induced neurologic disease
MT Liu et al.
JOURNAL OF IMMUNOLOGY (2000)
分享论文
